financetom
Business
financetom
/
Business
/
Silicon Laboratories Fiscal Q1 Loss Narrows as Revenue Rises; Fiscal Q2 Outlook Issued
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Silicon Laboratories Fiscal Q1 Loss Narrows as Revenue Rises; Fiscal Q2 Outlook Issued
May 26, 2025 6:38 AM

07:31 AM EDT, 05/13/2025 (MT Newswires) -- Silicon Laboratories ( SLAB ) reported a fiscal Q1 loss Tuesday of $0.94 per diluted share, narrowing from a loss of $1.77 a year earlier.

Analysts polled by FactSet expected a loss of $0.82.

Revenue for the quarter ended April 5 was $177.7 million, up from $106.4 million a year earlier.

Analysts surveyed by FactSet expected $177.5 million.

The company said it expects fiscal Q2 adjusted loss of $0.01 to adjusted earnings of $0.19 per diluted share on revenue of $185 million to $200 million. Analysts surveyed by FactSet expect adjusted earnings of $0.03 on revenue of $188.1 million.

Shares of the company rose nearly 2% in recent Tuesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
4D Molecular Therapeutics Accelerates Wet AMD Trial, Cuts Jobs to Offset Costs
4D Molecular Therapeutics Accelerates Wet AMD Trial, Cuts Jobs to Offset Costs
Jul 2, 2025
05:00 PM EDT, 07/02/2025 (MT Newswires) -- 4D Molecular Therapeutics ( FDMT ) said late Wednesday that it is accelerating its Phase 3 program for the 4D-150 gene therapy for wet age-related macular degeneration, citing stronger-than-expected enrollment and site activation in its North American trial. The company cut 25% of its workforce, mainly in early-stage research and development and support...
BRIEF-Old Point Announces Shareholder Approval For Merger
BRIEF-Old Point Announces Shareholder Approval For Merger
Jul 2, 2025
July 2 (Reuters) - Old Point Financial Corp ( OPOF ): * OLD POINT ANNOUNCES SHAREHOLDER APPROVAL FOR MERGER Source text: Further company coverage: ...
Golden pass asks US regulators for permission to re-export LNG from Oct 1
Golden pass asks US regulators for permission to re-export LNG from Oct 1
Jul 2, 2025
HOUSTON, July 2 (Reuters) - Golden Pass LNG, which is owned by Exxon Mobil ( XOM ) and QatarEnergy, has asked U.S. regulators for permission to re-export liquefied natural gas from October 1. The company has said it wants to re-export a cargo of LNG it plans to import to cool down its export plant in Texas which is still...
Copyright 2023-2026 - www.financetom.com All Rights Reserved